Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

North Carolina

CNS medication trials in North Carolina

67 CNS medication studies are recruiting participants at sites in 21 cities across North Carolina as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every North Carolina city with a recruiting study

By research area: Depression (20), Migraine (13), Epilepsy (11), Parkinson's Disease (10), Multiple Sclerosis (8), Schizophrenia (4), ADHD (1).

Charlotte (22), Durham (16), Raleigh (12), Winston-Salem (11), Chapel Hill (9), Asheville (5), Cary (5), Greensboro (5), Matthews (2), Morehead City (2), Morrisville (2), Rose Hill (2), Shelby (2), Hickory (1), Huntersville (1), Jacksonville (1), Kinston (1), Pinehurst (1), Salisbury (1), Statesville (1), Wilmington (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in North Carolina

Basic details from each study's public record (the 12 most recently updated of 67). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Charlotte
    Registry record
    NCT07226661 · updated
  2. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Recruiting in
    Chapel Hill
    Registry record
    NCT07002034 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in North Carolina on ClinicalTrials.gov.

Parkinson's disease: recently updated in North Carolina

  1. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Charlotte · Winston-Salem
    Registry record
    NCT06623422 · updated
  2. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Durham · Pinehurst
    Registry record
    NCT06952504 · updated
  3. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Charlotte · Winston-Salem
    Registry record
    NCT06989112 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in North Carolina on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in North Carolina

  1. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Raleigh
    Registry record
    NCT07067463 · updated
  2. A Study of AZD0120 in Autoimmune Diseases

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Chapel Hill
    Registry record
    NCT07295847 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in North Carolina on ClinicalTrials.gov.

Epilepsy: recently updated in North Carolina

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Asheville
    Registry record
    NCT07563881 · updated
  2. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Raleigh
    Registry record
    NCT07594119 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in North Carolina on ClinicalTrials.gov.

Migraine: recently updated in North Carolina

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Charlotte · Salisbury · Winston-Salem
    Registry record
    NCT06972056 · updated
  2. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    Asheville · Raleigh
    Registry record
    NCT07616128 · updated
  3. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Cary · Morehead City · Raleigh · and 2 more U.S. locations
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in North Carolina on ClinicalTrials.gov.

Ask about studies in North Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call